Pediatrix Medical Group's stock plummeted 15.79% during Thursday's intraday trading session. The sharp decline came as the market reacted to the company's latest financial results.

The healthcare services provider reported fourth-quarter adjusted earnings per share of $0.50, missing the analyst consensus estimate of $0.54. Additionally, the company's adjusted EBITDA of $65.845 million fell short of the estimated $71.1 million. While quarterly revenue of $493.771 million surpassed expectations, the earnings disappointment on key profitability metrics drove negative investor sentiment.

The company also provided its preliminary outlook for fiscal year 2026, projecting adjusted EBITDA in the range of $280 million to $300 million. The mixed financial picture, featuring an earnings miss alongside a revenue beat, appears to have prompted the significant sell-off in the stock.